ABOUT INHERENT
The International Hemoglobinopathy Research Network (INHERENT) was formed in 2020 with the primary aim to study the role of genetic modifiers in hemoglobinopathies through a large, multi-ethnic genome-wide association study (GWAS). The target sample size of INHERENT is at least 30,000 individuals with hemoglobinopathies. Therefore, INHERENT will address the challenges of previous studies related to small sample sizes and low statistical power, while promoting the participation of diverse populations worldwide.
JOIN INHERENT
Participation is open to any group that can submit to the study a minimum of 30 samples with their core phenotypic description.
If you are interested please contact Dr Petros Kountouris at [email protected]
INHERENT serves as an umbrella network,
bringing together international and regional initiatives under a common framework.
